Metabolic & Cardiometabolic
Part of Biotech - Drug Development
| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
 LLY | Eli Lilly & Co. | $0.8t | $984.53 | -2.0% | 1.4M |
 AZN | AstraZeneca PLC | $289.5b | $183.97 | +1.3% | 870.0K |
 MDGL | Madrigal Pharmaceuticals, Inc. Common Stock | $11.9b | $518.29 | -1.0% | 198.5K |
 PTGX | Protagonist Therapeutics, Inc | $6.5b | $101.08 | -1.1% | 259.7K |
 TERN | Terns Pharmaceuticals, Inc. Common Stock | $6.1b | $52.97 | +0.0% | 2.3M |
 KNSA | Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares | $4.1b | $53.77 | -4.8% | 385.8K |
 TVTX | Travere Therapeutics, Inc. Common Stock | $3.8b | $42.92 | +0.8% | 884.4K |
 VKTX | Viking Therapeutics, Inc | $3.8b | $28.49 | -5.9% | 2.7M |
 NAMS | NewAmsterdam Pharma Company N.V. Ordinary Shares | $3.3b | $33.94 | -4.2% | 1.4M |
 MLYS | Mineralys Therapeutics, Inc. Common Stock | $2.1b | $26.48 | -3.3% | 648.5K |
 MAZE | Maze Therapeutics, Inc. Common Stock | $1.4b | $24.25 | -5.1% | 412.0K |
 MBX | MBX Biosciences, Inc. Common Stock | $1.4b | $31.00 | -4.5% | 697.6K |
 SEPN | Septerna, Inc. Common Stock | $1.1b | $26.35 | -2.2% | 235.6K |
 MNKD | Mannkind Corporation | $0.9b | $3.02 | -2.4% | 3.6M |
 BIOA | BioAge Labs, Inc. Common Stock | $0.8b | $15.52 | -12.1% | 349.9K |
 GYRE | Gyre Therapeutics, Inc. Common Stock | $0.7b | $6.42 | -2.0% | 66.1K |
 LXRX | Lexicon Pharmaceuticals, Inc. | $0.7b | $2.10 | -5.6% | 1.9M |
 ALT | Altimmune, Inc. Common Stock | $0.5b | $2.77 | -2.6% | 2.6M |
 ESPR | Esperion Therapeutics, Inc. | $491.6m | $3.13 | +0.5% | 11.2M |
 TENX | Tenax Therapeutics, Inc. | $376.3m | $11.46 | -4.3% | 724.9K |
 RZLT | Rezolute, Inc. Common Stock (NV) | $293.8m | $3.25 | -2.5% | 950.1K |
 SGMT | Sagimet Biosciences Inc. Series A Common Stock | $285.1m | $6.63 | -3.8% | 1.0M |
 MIST | Milestone Pharmaceuticals Inc. Common Shares | $217.7m | $1.49 | -1.3% | 1.1M |
 ORMP | Oramed Pharmaceuticals Inc. | $163.0m | $4.28 | -7.8% | 360.2K |
 CRDL | Cardiol Therapeutics Inc. Class A Common Shares | $153.0m | $1.28 | -2.7% | 426.6K |
 VTVT | vTv Therapeutics Inc. Class A Common Stock | $125.9m | $35.90 | +0.6% | 43.0K |
 AARD | Aardvark Therapeutics, Inc. Common Stock | $122.0m | $4.29 | -6.0% | 231.4K |
 VANI | Vivani Medical, Inc. Common Stock (DE) | $116.0m | $1.15 | -2.0% | 116.3K |
 BMEA | Biomea Fusion, Inc. Common Stock | $110.6m | $1.25 | -7.0% | 1.3M |
 GUTS | Fractyl Health, Inc. Common Stock | $104.1m | $0.79 | -8.6% | 1.9M |
 ALGS | Aligos Therapeutics, Inc. Common Stock | $38.9m | $5.38 | -5.7% | 149.8K |
 VERU | Veru Inc. | $36.8m | $2.11 | 0.0% | 77.8K |
 SKYE | Skye Bioscience, Inc. Common Stock | $32.7m | $0.78 | -4.1% | 91.1K |
 LPCN | Lipocine Inc. | $18.5m | $2.23 | -1.3% | 73.3K |
 NCEL | NewcelX Ltd. Ordinary Shares | $16.9m | $3.08 | -4.0% | 9.6K |
 CVKD | Cadrenal Therapeutics, Inc. Common Stock | $13.4m | $4.95 | -2.1% | 43.3K |
 CURX | Curanex Pharmaceuticals Inc Common Stock | $12.1m | $0.31 | +2.6% | 19.1K |
 ELAB | PMGC Holdings Inc. Common Stock | $11.3m | $1.94 | -6.7% | 375.1K |
 MTVA | MetaVia Inc. Common Stock | $8.4m | $1.12 | +1.2% | 44.4K |
 GRDX | GridAI Technologies Corp. Common Stock | $7.5m | $3.83 | -1.0% | 73.2K |
 TCRT | Alaunos Therapeutics, Inc. Common Stock | $6.2m | $2.59 | +4.8% | 22.6K |
 GLMD | Galmed Pharmaceuticals Ltd. | $3.9m | $0.59 | -1.0% | 53.1K |